AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Edwards Lifesciences Corp
XNYS · usd
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG001SF2288
89.07▼ 1.02 (-1.13%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
90.09
Day's Range
88.97 – 91.05
52-Week Range
74.66 – 96.29
Volume
3.1M
Avg Volume
3.6M
Share Statistics
Shares Outstanding
Employees
16.0K
Exchange
XNYS
Listed
2000-04-03
Share count as of July 31, 2026

Edwards Lifesciences Corp (EW) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Edwards Lifesciences Corp (EW)
What is Edwards Lifesciences Corp's Market Cap?
Edwards Lifesciences Corp's Market Cap is $51.3B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Enterprise Value?
Edwards Lifesciences Corp's Enterprise Value is $47.7B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Trailing P/E?
Edwards Lifesciences Corp's Trailing P/E is 51.1×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Price / Sales?
Edwards Lifesciences Corp's Price / Sales is 7.9×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EV / Revenue?
Edwards Lifesciences Corp's EV / Revenue is 7.3×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EV / EBITDA?
Edwards Lifesciences Corp's EV / EBITDA is 29.5×, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Revenue (TTM)?
Edwards Lifesciences Corp's Revenue (TTM) is $6.5B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Net Income (TTM)?
Edwards Lifesciences Corp's Net Income (TTM) is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's EBITDA?
Edwards Lifesciences Corp's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Edwards Lifesciences Corp's Diluted EPS (TTM)?
Edwards Lifesciences Corp's Diluted EPS (TTM) is 1.74, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · EWAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+13.6%+16.7%+13.3%+14.7%
Cost of sales
Gross profit
% of revenue77.5%78.0%78.1%77.8%
Selling, general, and administrative expenses
Research and development expenses
Certain litigation expenses
Separation costs——
Other operating income
Operating income, net
% of revenue29.5%29.0%9.6%19.8%
Interest income, net
Loss on impairment (Note 6)
Other non-operating (income) expense, net (Note 7)
Income from continuing operations before provision for income taxes
Provision for income taxes
Net income from continuing operations
Net income
% of revenue13.9%23.1%5.8%18.7%
Less: Net loss attributable to noncontrolling interest
Net income attributable to Edwards Lifesciences Corporation
% of revenue13.9%23.1%5.8%18.7%
Basic earnings per share (in dollars per share)
Diluted earnings per share (in dollars per share)